• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部区域性前列腺癌患者前列腺特异性抗原水平的种族差异。

Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.

作者信息

Vijayakumar S, Karrison T, Weichselbaum R R, Chan S, Quadri S F, Awan A M

机构信息

Michael Reese/University of Chicago Center for Radiation Therapy 60616.

出版信息

Cancer Epidemiol Biomarkers Prev. 1992 Nov-Dec;1(7):541-5.

PMID:1284591
Abstract

Prostate cancer is a significant health problem for blacks. The incidence and mortality rates are higher in blacks than in whites; blacks often present with a higher stage. Prostate-specific antigen (PSA) is a very useful serum marker in prostate cancer. We analyzed data from a cohort of 161 patients to determine whether there were any racial differences in PSA levels prior to treatment in local-regional prostate cancer. The immunoradiometric method was used to determine the PSA values. The mean PSA levels were significantly higher in blacks than in whites (P = 0.022), and the difference remained significant in multivariate analysis after adjusting for stage and grade (P = 0.020). However, when analyzed further, the difference was statistically significant in one hospital (P = 0.001) and not in another (P = 0.493). Thus, our results are not unequivocal, but our data do suggest that racial differences in PSA levels not accounted for by tumor stage or grade may exist. Assuming that the data truly reflect a racial difference, the cause(s) of this difference remains to be determined. It may exist because, within each clinical stage, blacks are presenting with a higher tumor cell burden, or it may be indicative of more aggressive biological behavior. The possibility that racial differences are due to socioeconomic factors was considered by estimating median income level from zip code of residence; although a correlation between socioeconomic status and PSA level was found, racial differences remained borderline significant (P = 0.055) after adjusting for income level (in addition to stage and grade).

摘要

前列腺癌是黑人面临的一个重大健康问题。黑人的发病率和死亡率高于白人;黑人通常就诊时分期较高。前列腺特异性抗原(PSA)是前列腺癌中一种非常有用的血清标志物。我们分析了161例患者队列的数据,以确定局部区域前列腺癌患者治疗前PSA水平是否存在种族差异。采用免疫放射分析法测定PSA值。黑人的平均PSA水平显著高于白人(P = 0.022),在调整分期和分级后进行多变量分析时,差异仍然显著(P = 0.020)。然而,进一步分析时,在一家医院差异具有统计学意义(P = 0.001),而在另一家医院则无统计学意义(P = 0.493)。因此,我们的结果并不明确,但我们的数据确实表明,可能存在未被肿瘤分期或分级所解释的PSA水平种族差异。假设这些数据真实反映了种族差异,这种差异的原因仍有待确定。可能是因为在每个临床分期内,黑人的肿瘤细胞负荷更高,或者这可能表明其生物学行为更具侵袭性。通过根据居住邮政编码估算收入中位数水平,考虑了种族差异是否由社会经济因素导致;尽管发现社会经济地位与PSA水平之间存在相关性,但在调整收入水平(以及分期和分级)后,种族差异仍接近显著水平(P = 0.055)。

相似文献

1
Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.局部区域性前列腺癌患者前列腺特异性抗原水平的种族差异。
Cancer Epidemiol Biomarkers Prev. 1992 Nov-Dec;1(7):541-5.
2
Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.局部区域性前列腺癌患者前列腺特异性抗原水平的种族差异。
Prostate. 1997 Apr 1;31(1):42-6. doi: 10.1002/(sici)1097-0045(19970401)31:1<42::aid-pros7>3.0.co;2-k.
3
Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status.非裔美国人的前列腺特异性抗原水平与作为社会经济地位指标的保险状况相关。
Cancer J Sci Am. 1996 Jul-Aug;2(4):225-33.
4
Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12.在一项多中心注册研究中,非裔美国患者的前列腺特异性抗原水平高于白人患者:放射治疗肿瘤学组94-12研究结果
Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):17-25. doi: 10.1016/s0360-3016(97)00834-1.
5
Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.前列腺癌患者前列腺特异性抗原水平及前列腺特异性抗原密度的种族差异。
Am J Clin Oncol. 1999 Dec;22(6):537-41. doi: 10.1097/00000421-199912000-00001.
6
A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.一项针对患有前列腺癌的黑人和白人男性血清前列腺特异性抗原浓度及Gleason组织学评分的前瞻性研究。
Cancer. 1999 Sep 1;86(5):836-41.
7
Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.前列腺癌的面貌改变与不同表现:前列腺特异性抗原(PSA)时代中PSA、分期及分级趋势的种族和地理差异
Int J Cancer. 2001 Dec 20;96(6):363-71. doi: 10.1002/ijc.1035.
8
Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients.根治性前列腺切除术患者肿瘤体积和前列腺特异性抗原的种族差异。
J Urol. 1999 Aug;162(2):394-7.
9
The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.在一所大学医院及其社区附属医院就诊的前列腺癌患者两个连续时间段内,初始前列腺特异性抗原(PSA)与种族之间的关联。
Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1292-6. doi: 10.1016/s0360-3016(03)00771-5.
10
Heterogeneous methodology of racial/ethnic classification may be responsible for the different risk assessments for prostate cancer between Black and White men in Brazil.种族/族裔分类方法的异质性可能是巴西黑人和白人男性前列腺癌风险评估不同的原因。
Int Braz J Urol. 2015 Mar-Apr;41(2):360-6. doi: 10.1590/S1677-5538.IBJU.2015.02.25.

引用本文的文献

1
Do African-American men need separate prostate cancer screening guidelines?非裔美国男性是否需要单独的前列腺癌筛查指南?
BMC Urol. 2016 May 10;16(1):19. doi: 10.1186/s12894-016-0137-7.
2
Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.种族、遗传的西非血统以及前列腺特异性抗原在前列腺癌前瞻性筛查高危男性中的预测作用
Cancer Prev Res (Phila). 2009 Mar;2(3):244-50. doi: 10.1158/1940-6207.CAPR-08-0150. Epub 2009 Feb 24.
3
Prostate cancer: epidemiology and screening.
前列腺癌:流行病学与筛查
Rev Urol. 2000;2 Suppl 4(Suppl 4):S5-9.
4
Screening for prostate cancer in African Americans.非裔美国人前列腺癌的筛查
Curr Urol Rep. 2000 May;1(1):57-64. doi: 10.1007/s11934-000-0036-y.
5
Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients.非裔美国人和白人正常受试者及前列腺癌患者体内的前列腺特异性抗原与雄激素
J Natl Med Assoc. 2000 Sep;92(9):445-9.
6
Racial differences in the androgen/androgen receptor pathway in prostate cancer.前列腺癌中雄激素/雄激素受体通路的种族差异。
J Natl Med Assoc. 1999 Dec;91(12):653-60.
7
Molecular genetics of prostate cancer: clinical applications.前列腺癌的分子遗传学:临床应用
J Natl Med Assoc. 1998 Nov;90(11 Suppl):S728-31.
8
Similar clinical outcomes in African-American and non-African-American males treated with suramin for metastatic prostate cancer.使用苏拉明治疗转移性前列腺癌的非裔美国男性和非非裔美国男性具有相似的临床结果。
J Natl Med Assoc. 1997 Sep;89(9):622-8.